Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors

Shcherbakov, D.; Baev, D.; Kalinin, M.; Dalinger, A.; Chirkova, V.; Belenkaya, S.; Khvostov, A.; Krut’ko, D.; Medved’ko, A.; Volosnikova, E.; Sharlaeva, E.; Shanshin, D.; Tolstikova, T.; Yarovaya, O.; Maksyutov, R.; Salakhutdinov, N.; Vatsadze, S.

Авторы: Shcherbakov Dmitriy, Baev Dmitriy, Kalinin Mikhail, Dalinger Alexander, Chirkova Varvara, Belenkaya Svetlana, Khvostov Aleksei, Krut’ko Dmitry, Medved’ko Aleksei, Volosnikova Ekaterina, Sharlaeva Elena, Shanshin Daniil, Tolstikova Tatyana, Yarovaya Olga, Maksyutov Rinat, Salakhutdinov Nariman, Vatsadze Sergey
Журнал: ACS Medicinal Chemistry Letters
Том: 13
Номер: 1
Год издания: 2022
Издательство: American Chemical Society
Местоположение издательства: United States
Первая страница: 140
Последняя страница: 147
Номер статьи: acsmedchemlett.1c00299
DOI: 10.1021/acsmedchemlett.1c00299
Аннотация: For the first time, derivatives of 3,7-diazabicyclo[3.3.1]nonane (bispidine) were proposed as potential inhibitors of the SARS-CoV-2 main viral protease (3-chymotrypsin-like,3CLpro). Based on the created pharmacophore model of the active site of the protease, a group of compounds were modeled and tested for activity against 3CLpro. The 3CLpro activity wasmeasured using the fluorogenic substrate Dabcyl-VNSTLQSGLRK(FAM)MA; the efficiency of the proposed approach was confirmed by comparison with literature data for ebselen and disulfiram. The results of the experiments performed withbispidine compounds showed that 14 compounds exhibited activity in the concentration range 1−10 μM, and 3 samples exhibited submicromolar activity. The structure−activity relationship studies showed that the molecules containing a carbonyl group in the ninth position of the bicycle exhibited the maximum activity. Based on the experimental and theoretical results obtained, further directions for the development of this topic were proposed.
Добавил в систему: Вацадзе Сергей Зурабович

	ИСТИНА	Войти в систему Регистрация
	ИСТИНА ИНХС РАН
	Главная Поиск Статистика О проекте Помощь

ИСТИНА

ИСТИНА ИНХС РАН

Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitorsстатья Исследовательская статья

Прикрепленные файлы